FDA - Spark Newswire

2 minute read

FDA
News

Vir Biotechnology Shares Move Lower; Co, WuXi Biologics Terminate A Greater China Collaboration Agreement For Antibodies Including VIR-7831

Today, 4:29 PM

As previously disclosed, Vir Biotechnology, Inc. (the “Company”) and WuXi Biologics (Hong Kong) Limited (“WuXi Bio”) entered into a Development and Manufacturing Collaboration Agreement dated

VIR

1 minute read

FDA Approves Regeneron and Sanofi’s Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule

By Ragothaman Srinivasan

Today, 4:08 PM

The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc.

REGN

5 minute read

FDA
News

Vera Therapeutics Announces New Atacicept Phase 2 Clinical Data In Two Oral Presentations At The 59th European Renal Association Congress

By Benzinga Newsdesk

Today, 4:06 PM

Vera Therapeutics Announces New Atacicept Phase 2 Clinical Data in Two Oral Presentations at the 59th European Renal Association Congress Atacicept is the first known investigational therapy to decrease both

VERA

4 minute read

Regeneron, Sanofi Report FDA Approved Dupixent As Treatment For Adults, Children Aged 12+ With Esophagitis

By Benzinga Newsdesk

Today, 3:16 PM

Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of FDA's Priority Review action date Dupixent 300 mg weekly

REGN

1 minute read

World Health Organization Confirms Will Convene A Meeting On Monkeypox Friday

By Benzinga Newsdesk

Today, 11:52 AM

-Reuters

AEMD

1 minute read

Why TherapeuticsMD Shares Are Trading Higher Today

By Vandana Singh

Today, 10:52 AM

TherapeuticsMD Inc (NASDAQ:TXMD) shares are trading higher after FDA approved the supplemental application, including minor revisions to Annovera’s in vitro release testing…

TXMD

7 minute read

FDA
News

Chinook Therapeutics Presents Data From Atrasentan Phase 2 AFFINITY IgA Nephropathy Patient Cohort And Evotec Collaboration At The 59th European Renal Association Congress 2022

By Benzinga Newsdesk

Today, 10:33 AM

Chinook Therapeutics Presents Data from Atrasentan Phase 2 AFFINITY IgA Nephropathy (IgAN) Patient Cohort and Evotec Collaboration at the 59th European Renal Association (ERA) Congress 2022 The AFFINITY IgAN cohort of

KDNY

2 minute read

Trinity Biotech Announces CE Mark Of Its 10-Minute Covid-19 Antigen Test

By Benzinga Newsdesk

Today, 9:21 AM

Trinity Biotech plc (NASDAQ:TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test

TRIB

1 minute read

Immix Biopharma Highlights Its IMX-110 Showed Improved Survival Over J&J’s Janssen’s FDA-Approved Drug Trabectedin Related To Connective Tissue Cancer Soft Tissue Sarcoma

By Benzinga Newsdesk

Today, 8:48 AM

One cycle of IMX-110 produced 75% survival vs. 0% survival for Trabectedin (sold as YONDELIS ® by Janssen, a Johnson & Johnson Company, a U.S. FDA approved drug) In a connective tissue cancer Soft Tissue

IMMX